AGEN

NASDAQ · Biotechnology

Agenus Inc

Small-Cap Stocks Stocks Under $10 Biotech Stocks Healthcare Stocks

$9.43

+0.89 (+10.42%)

As of Sep 28, 10:22 PM ET ·

Financial Highlights (FY 2026)

Revenue

175.18M

Net Income

177.9K

Gross Margin

99.1%

Profit Margin

0.1%

Rev Growth

+5.2%

D/E Ratio

0.41

Revenue & Net Income

Margin Trends

	FY 2026	FY 2025	FY 2024	FY 2023
Gross Margin	99.1%	99.1%	42.9%	42.9%
Operating Margin	70.5%	63.5%	-12.1%	-11.8%
Profit Margin	0.1%	0.1%	-13.6%	-13.8%

Income Statement

	FY 2026	FY 2025	FY 2024	FY 2023
Revenue	175.18M	166.48M	22.23M	24.20M
Gross Profit	173.62M	165.00M	9.53M	10.37M
Operating Income	123.57M	105.69M	-2,685,737	-2,845,163
Net Income	177.9K	152.2K	-3,026,461	-3,348,387
Gross Margin	99.1%	99.1%	42.9%	42.9%
Operating Margin	70.5%	63.5%	-12.1%	-11.8%
Profit Margin	0.1%	0.1%	-13.6%	-13.8%
Rev Growth	+5.2%	+5.2%	+14.5%	+15.7%

Balance Sheet

	FY 2026	FY 2025	FY 2024	FY 2023
Total Debt	56.87M	56.87M	13.67M	12.56M
Total Equity	137.89M	137.89M	33.53M	40.20M
D/E Ratio	0.41	0.41	0.41	0.31

Cash Flow

	FY 2026	FY 2025	FY 2024	FY 2023
EBITDA	138.91M	125.42M	-4,014,681	-4,691,998
Free Cash Flow	—	—	-2,971,274	-2,303,520